The primacy of mania: A reconsideration of mood disorders

Athanasios Koukopoulos; S. Nassir Ghaemi

doi:10.1016/j.eurpsy.2008.07.006

The primacy of mania: A reconsideration of mood disorders

Published online by Cambridge University Press: 16 April 2020

Athanasios Koukopoulos and

S. Nassir Ghaemi

Show author details

Athanasios Koukopoulos*: Affiliation:
Centro Lucio Bini, 42, Via Crescenzio, 00193Rome, Italy
S. Nassir Ghaemi: Affiliation:
Mood Disorders Program, Department of Psychiatry, Tufts Medical Center, Boston, MA, USA
*: *Corresponding author. Tel.: +39 06 687 4727; fax: +39 06 6880 2345. E-mail address: a.koukopoulos@fastwebnet.it ((A. Koukopoulos).

Article contents

Abstract
References

Get access

Abstract

In contemporary psychiatry, depression and mania are conceived as different entities. They may occur together, as in bipolar disorder, or they may occur separately, as in unipolar depression. This view is partly based on a narrow definition of mania and a rather broad definition of depression. Generally, depression is seen as more prominent, common, and problematic; while mania appears uncommon and treatment-responsive. We suggest a reversal: mania viewed broadly, not as simply episodic euphoria plus hyperactivity, but a wide range of excitatory behaviors; and depression seen more narrowly. Further, using pharmacological and clinical evidence, and in contrast to previous theories of mania interpreted as a flight from depression, we propose the primacy of mania hypothesis (PM): depression is a consequence of the excitatory processes of mania. If correct, current treatment of depressive illness needs revision. Rather than directly lifting mood with antidepressants, the aim would be to suppress manic-like excitation, with depression being secondarily prevented. Potential objections to, and empirical tests of, the PM hypothesis are discussed.

Keywords

Bipolar disorder Mania Depression Prophylaxis Antidepressants Lithium Antipsychotics Mood stabilizers ECT Suicide

Type: Original article
Information: European Psychiatry , Volume 24 , Issue 2 , March 2009 , pp. 125 - 134

DOI: https://doi.org/10.1016/j.eurpsy.2008.07.006 [Opens in a new window]
Copyright: Copyright © Elsevier Masson SAS 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Akiskal, H.S.The bipolar spectrum: new concepts in classification and diagnosisGrinspoon, L.Washington DCPsychiatry update; the American Psychiatric Association Annual Review, vol. 2 American Psychiatric Press 1983 271–292Google Scholar

Akiskal, H.S.Toward a temperament-based approach to depression: implications for neurobiologic research. Adv Biochem Psychopharmacol 1995;49:99–112Google Scholar

Akiskal, H.S., Benazzi, F.Optimizing the detection of bipolar II disorder in outpatient private practice: toward a systematization of clinical diagnostic wisdom. J Clin Psychiatry 2005;66(7):914–921CrossRef Google Scholar

Akiskal, H.S., Benazzi, F., Perugi, G., Rihmer, Z.Agitated “unipolar” depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy. J Affect Disord 2005;85(3):245–258CrossRef Google Scholar PubMed

Akiskal, H.S., Hantouche, E.G., Allilaire, J.F.Bipolar II with and without cyclothymic temperament: “dark” and “sunny” expressions of soft bipolarity. J Affect Disord 2003;73(1-2):49–57CrossRef Google Scholar PubMed

Akiskal, H.S., Pinto, O.The evolving bipolar spectrum. Prototypes I, II, III, and IV. Psychiatr Clin North Am 1999;22(3):517–534 viiCrossRef Google Scholar PubMed

Ali, S., Milev, R.Switch to mania upon discontinuation of antidepressants in patients with mood disorders: a review of the literature. Can J Psychiatry 2003;48(4):258–264CrossRef Google Scholar PubMed

Alnaes, R., Torgersen, S.Mood disorders: developmental and precipitating events. Can J Psychiatry 1993;38(3):217–224CrossRef Google Scholar PubMed

Altshuler, L., Kiriakos, L., Calcagno, J., Goodman, R., Gitlin, M., Frye, M.et al.The impact of antidepressant discontinuation versus antidepressant continuation on 1-year risk for relapse of bipolar depression: a retrospective chart review. J Clin Psychiatry 2001;62(8):612–616CrossRef Google Scholar PubMed

Altshuler, L., Suppes, T., Black, D., Nolen, W.A., Keck, P.E. Jr.Frye, M.A.et al.Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up. Am J Psychiatry 2003;160(7):1252–1262CrossRef Google Scholar PubMed

Amsterdam, J.D.Efficacy and safety of venlafaxine in the treatment of bipolar II major depressive episode. J Clin Psychopharmacol 1998;18:414–417CrossRef Google Scholar PubMed

Amsterdam, J.D., Garcia-Espana, F., Fawcett, J., Quitkin, F.M., Reimherr, F.W., Rosenbaum, J.R.et al.Efficacy and safety of fluoxetine in treating bipolar II major depressive episode. J Clin Psychopharmacol 1998;18:435–440CrossRef Google Scholar PubMed

Angst, J.On the etiology and nosology of endogenous depressive psychoses: a genetic, sociologic, and clinical study. Monogr Gesamtgeb Neurol Psychiatr 1966;112:1–118Google Scholar PubMed

Angst, J.Switch from depression to mania – a record study over decades between 1920 and 1982. Psychopathology 1985;18:140–154CrossRef Google Scholar

Baastrup, P.C., Poulsen, J.C., Schou, M., Thomsen, K., Amdisen, A.Prophylactic lithium: double blind discontinuation in manic-depressive and recurrent-depressive disorders. Lancet 1970(Aug 15);2(7668):326–330CrossRef Google Scholar

Baastrup, P.C., Schou, M.Lithium as a prophylactic agent. Arch Gen Psychiatry 1967;16:162–172CrossRef Google Scholar

Bauer, M., Adli, M., Baethge, C., Berghofer, A., Sasse, J., Heinz, A.et al.Lithium augmentation therapy in refractory depression: clinical evidence and neurobiological mechanisms. Can J Psychiatry 2003;48(7):440–448CrossRef Google Scholar PubMed

Bebbington, P.E., Brugha, T., MacCarthy, B., Potter, J., Sturt, E., Wykes, T.et al.The Camberwell Collaborative Depression Study. I. Depressed probands: adversity and the form of depression. Br J Psychiatry 1988;152:754–765CrossRef Google Scholar

Benazzi, F.Depressive mixed state: testing different definitions. Psychiatry Clin Neurosci 2001;55(6):647–652CrossRef Google Scholar PubMed

Benazzi, F.Reviewing the diagnostic validity and utility of mixed depression (depressive mixed states). Eur Psychiatry 2008;23(1):40–48CrossRef Google Scholar

Berk, M., Dodd, S.Are treatment emergent suicidality and decreased response to antidepressants in younger patients due to bipolar disorder being misdiagnosed as unipolar depression?. Med Hypotheses 2005;65(1):39–43CrossRef Google Scholar PubMed

Berrios, G., Porter, R.A history of clinical psychiatry New YorkNew York University Press 1995Google Scholar

Berrios, G.E.Of mania: introduction (Classic text no. 57). Hist Psychiatry 2004;15(57 Pt 1):105–124CrossRef Google Scholar

Bowden, C., Calabrese, J., Sachs, G., Yatham, L., Asghar, S., Hompland, M.et al.A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003;60:392–400CrossRef Google Scholar PubMed

Brown, E.B., McElroy, S.L., Keck, P.E. Jr.Deldar, A., Adams, D.H., Tohen, M.et al.A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression. J Clin Psychiatry 2006;67(7):1025–1033CrossRef Google Scholar PubMed

Burgess, S., Geddes, J., Hawton, K., Townsend, E., Jamison, K., Goodwin, G. Lithium for maintenance treatment of mood disorders. Cochrane Database Syst Rev 2001; (3):CD003013CrossRef Google Scholar

Calabrese, J.R., Bowden, C.L., Sachs, G.S., Ascher, J.A., Monaghan, E., Rudd, G.D.A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry 1999;60(2):79–88CrossRef Google Scholar PubMed

Calabrese, J., Bowden, C., Sachs, G., Yatham, L., Behnke, K., Mehtonen, O.et al.A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 2003;64(9):1013–1024CrossRef Google Scholar PubMed

Calabrese, J.R., Huffman, R.F., White, R.L., Edwards, S., Thompson, T.R., Ascher, J.A.et al.Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials. Bipolar Disord 2008;10(2):323–333CrossRef Google Scholar PubMed

Calabrese, J.R., Keck, P.E. Jr.Macfadden, W., Minkwitz, M., Ketter, T.A., Weisler, R.H.et al.A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 2005;162(7):1351–1360CrossRef Google Scholar PubMed

Cassano, G.B., Akiskal, H.S., Savino, M., Musetti, L., Perugi, G.Proposed subtypes of bipolar II and related disorders: with hypomanic episodes (or cyclothymia) and with hyperthymic temperament. J Affect Disord 1992;26(2):127–140CrossRef Google Scholar PubMed

Cassano, G.B., Rucci, P., Frank, E., Fagiolini, A., Dell’Osso, L., Shear, M.K.et al.The mood spectrum in unipolar and bipolar disorder: arguments for a unitary approach. Am J Psychiatry 2004;161(7):1264–1269CrossRef Google Scholar PubMed

Cassidy, F., Murry, E., Forest, K., Carroll, B.Signs and symptoms of mania in pure and mixed episodes. J Affect Disord 1998;50:187–201CrossRef Google Scholar PubMed

Cioran, E.On the heights of despair ChicagoUniversity of Chicago Press 1992Google Scholar

Cipriani, A., Smith, K., Burgess, S., Carney, S., Goodwin, G., Geddes, J. Lithium versus antidepressants in the long-term treatment of unipolar affective disorder. Cochrane Database Syst Rev 2006; (4):CD003492CrossRef Google Scholar

Coryell, W., Solomon, D., Turvey, C., Keller, M., Leon, A.C., Endicott, J.et al.The long-term course of rapid-cycling bipolar disorder. Arch Gen Psychiatry 2003;60(9):914–920CrossRef Google Scholar PubMed

Court, J.H.The continuum model as a resolution of paradoxed in manic-depressie psychosis. Br J Psychiatry 1972;120(555):133–141CrossRef Google Scholar PubMed

De Fruyt, J., Demyttenaere, K.Bipolar (spectrum) disorder and mood stabilization: standing at the crossroads?. Psychother Psychosom 2007;76(2):77–88CrossRef Google Scholar PubMed

Didham, R.C., McConnell, D.W., Blair, H.J., Reith, D.M.Suicide and self-harm following prescription of SSRIs and other antidepressants: confounding by indication. Br J Clin Pharmacol 2005;60(5):519–525CrossRef Google Scholar PubMed

Dilsaver, S., Chen, Y., Swann, A., Shoaib, A., Krajewski, K.J.Suicidality in patients with pure and depressive mania. Am J Psychiatry 1994;151:1312–1315Google Scholar PubMed

Dilsaver, S.C., Greden, J.F.Antidepressant withdrawal-induced activation (hypomania and mania): is withdrawal-induced cholinergic overdrive causally significant?. J Clin Psychopharmacol 1984;4(3):174–175CrossRef Google Scholar PubMed

Fava, M.New approaches to the treatment of refractory depression. J Clin Psychiatry 2000;61(Suppl 1(4))):26–32Google Scholar PubMed

Fava, M., Alpert, J., Nierenberg, A., Lagomasino, I., Sonawalla, S., Tedlow, J.et al.Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders and nonresponders to fluoxetine. J Clin Psychopharmacol 2002;22(4):379–387CrossRef Google Scholar PubMed

Frank, E., Gonzalez, J.M., Fagiolini, A.The importance of routine for preventing recurrence in bipolar disorder. Am J Psychiatry 2006;163(6):981–985CrossRef Google Scholar PubMed

Geddes, J.R., Burgess, S., Hawton, K., Jamison, K., Goodwin, G.M.Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry 2004;161(2):217–222CrossRef Google Scholar PubMed

Geller, B.Longitudinal course of a prepubertal and early adolescent bipolar disorder phenotypeFourth International Conference on Bipolar Disorder PittsburghPA USA 2001Google Scholar

Ghaemi, S.N.Bipolar disorder and antidepressants: an ongoing controversy. Primary Psychiatry 2001;8:28–34Google Scholar

Ghaemi, S.N., Boiman, E.E., Goodwin, F.K.Diagnosing bipolar disorder and the effect of antidepressants: a naturalistic study. J Clin Psychiatry 2000;61(10):804–808CrossRef Google Scholar PubMed

Ghaemi, S.N., El-Mallakh, R.S., Baldassano, C.F., Ostacher, M.M., Pardo, T.B., Zablotsky, B.et al.A randomized clinical trial of efficacy and safety of long-term antidepressant use in bipolar disorder (abstract). Bipolar Disord 2005;7(Suppl 2):59Google Scholar

Ghaemi, S.N., Goodwin, F.K.Antidepressants for bipolar depression. Am J Psychiatry 2005;162(8):1545–1546CrossRef Google Scholar PubMed

Ghaemi, S.N., Hsu, D.J., Soldani, F., Goodwin, F.K.Antidepressants in bipolar disorder: the case for caution. Bipolar Disord 2003;5(6):421–433CrossRef Google Scholar PubMed

Ghaemi, S.N., Rosenquist, K.J., Ko, J.Y., Baldassano, C.F., Kontos, N.J., Baldessarini, R.J.Antidepressant treatment in bipolar versus unipolar depression. Am J Psychiatry 2004;161(1):163–165CrossRef Google Scholar PubMed

Ghaemi, S.N., Sachs, G.S., Chiou, A.M., Pandurangi, A.K., Goodwin, F.K.Is bipolar disorder still underdiagnosed? Are antidepressants overutilized?. J Affect Disord 1999;52:135–144CrossRef Google Scholar PubMed

Gijsman, H.J., Geddes, J.R., Rendell, J.M., Nolen, W.A., Goodwin, G.M.Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. Am J Psychiatry 2004;161(9):1537–1547CrossRef Google Scholar PubMed

Goldberg, J.F., Ghaemi, S.N., Sachs, G.S.Antidepressants increase manic symptoms and do not improve depressive symptoms in bipolar depressive mixed states. Am J Psychiatry 2007;164:1348–1355CrossRef Google Scholar

Goldberg, J.F., Truman, C.J.Antidepressant-induced mania: an overview of current controversies. Bipolar Disord 2003;5(6):407–420CrossRef Google Scholar PubMed

Goldstein, T., Frye, M., Denicoff, K., Smith-Jackson, E., Leverich, G., Bryan, A.et al.Antidepressant discontinuation-related mania: critical prospective observation and theoretical implications in bipolar disorder. J Clin Psychiatry 1999;60(8):563–567CrossRef Google Scholar PubMed

Goodwin, G.M., Bowden, C.L., Calabrese, J.R., Grunze, H., Kasper, S., White, R.et al.A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry 2004;65(3):432–441CrossRef Google Scholar PubMed

Goodwin, F.K., Fireman, B., Simon, G.E., Hunkeler, E.M., Lee, J., Revicki, D.Suicide risk in bipolar disorder during treatment with lithium and divalproex. Jama 2003;290(11):1467–1473CrossRef Google Scholar PubMed

Goodwin, F., Jamison, K.Manic depressive illness 2nd ed.New YorkOxford University Press 2007Google Scholar

Griesinger, W.Pathologie und Therapie der psychischen Krankheiten StruttgartAdolf Krabbe Verlag 1861Google Scholar

Grof, E., Haag, M., Grof, P., Haag, H.Lithium response and the sequence of episode polarities: preliminary report on a Hamilton sample. Prog Neuropsychopharmacol Biol Psychiatry 1987;11(2-3):199–203CrossRef Google Scholar PubMed

Grunebaum, M.F., Ellis, S.P., Li, S., Oquendo, M.A., Mann, J.J.Antidepressants and suicide risk in the United States, 1985–1999. J Clin Psychiatry 2004;65(11):1456–1462CrossRef Google Scholar PubMed

Guzzetta, F., Tondo, L., Centorrino, F., Baldessarini, R.J.Lithium treatment reduces suicide risk in recurrent major depressive disorder. J Clin Psychiatry 2007;68(3):380–383CrossRef Google Scholar PubMed

Hammad, T.A., Laughren, T., Racoosin, J.Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry 2006;63(3):332–339CrossRef Google Scholar PubMed

Hartigan, G.P.Experiences of treatment with lithium salts. J Mental Sci 1961; (Suppl):49Google Scholar

Healy, D.The antidepressant era Cambridge, MAHarvard University Press 1998Google Scholar

Heinroth, J.Lehrbuch der Stroerungen des Seelenlebens LeipzigVogel 1818Google Scholar

Isacsson, G., Bergman, U., Rich, C.Epidemiological data suggest antidepressants reduce suicide risk among depressives. J Affect Disord 1996;41:1–8CrossRef Google Scholar PubMed

Jamison, K.An unquiet mind New YorkAlfred A. Knopf 1995Google Scholar

Jamison, K.Exuberance New YorkVintage 2004Google Scholar

Joffe, R.T., MacQueen, G.M., Marriott, M., Young, L.T.One-year outcome with antidepressant—treatment of bipolar depression. Acta Psychiatr Scand 2005;112(2):105–109CrossRef Google Scholar PubMed

Judd, L.L., Akiskal, H.S., Schettler, P.J., Endicott, J., Maser, J., Solomon, D.A.et al.The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002;59(6):530–537CrossRef Google Scholar PubMed

Kendler, K.S., Heath, A.C., Martin, N.G., Eaves, L.J.Symptoms of anxiety and symptoms of depression. Arch Gen Psychiatry 1987;44:451–457CrossRef Google Scholar PubMed

Kendler, K.S., Neale, M.C., Kessler, R.C.Major depression and generalized anxiety disorder: same genes, (partly) different environment?. Arch Gen Psychiatry 1992;49:716–722CrossRef Google Scholar

Khan, A., Detke, M., Khan, S.R., Mallinckrodt, C.Placebo response and antidepressant clinical trial outcome. J Nerv Ment Dis 2003;191(4):211–218CrossRef Google Scholar PubMed

Korkeila, J., Salminen, J.K., Hiekkanen, H., Salokangas, R.K.Use of antidepressants and suicide rate in Finland: an ecological study. J Clin Psychiatry 2007;68(4):505–511CrossRef Google Scholar

Koukopoulos, A., Albert, M.J., Sani, G., Koukopoulos, A.E., Girardi, P.Mixed depressive states: nosologic and therapeutic issues. Int Rev Psychiatry 2005;17(1):21–37CrossRef Google Scholar PubMed

Koukopoulos, A., Faedda, G., Proietti, R., D’Amico, S., de Pisa, E., Simonetto, C. [Mixed depressive syndrome]. Encephale 1992; 18 Spec No 1:19–21Google Scholar

Koukopoulos, A., Koukopoulos, A.Agitated depression as a mixed state and the problem of melancholia. Psychiatr Clin N Am 1999;22(3):547–564CrossRef Google Scholar PubMed

Koukopoulos, A., Reginaldi, P., Laddomada, G., Floris, G., Serra, G., Tondo, L.Course of the manic-depressive cycle and changes caused by treatments. Pharmakopsychiatrie 1980;13:156–167CrossRef Google Scholar

Koukopoulos, A., Reginaldi, D., Minnai, G., Serra, G., Pani, L., Johnson, F.N.The long-term prophylaxis of affective disordersGessa, G., Fratta, W., Pani, L., Serra, G.Depression and mania: from neurobiology to treatment New YorkRaven Press 1995Google Scholar

Koukopoulos, A., Sni, G., Koukopoulos, A., Girardi, P.Cyclicity and manic-depressive illnessMarneros, A., Angst, J.Bipolar disorders: 100 years after manic-depressive insanity LondonKluwer Academic Publishers 2000 315–334 0.25Google Scholar

Kraepelin, E.Psychiatrie LeipzigJA Barth 1913Google Scholar

Kukopulos, A., Caliari, B., Tundo, A., Minnai, G., Floris, G., Reginaldi, D.et al.Rapid cyclers, temperament, and antidepressants. Compr Psychiatry 1983;24(3):249–258CrossRef Google Scholar PubMed

Kukopulos, A., Reginaldi, D.Does lithium prevent depressions by suppressing manias?. Int Pharmacopsychiatry 1973;8(3):152–158CrossRef Google Scholar PubMed

Kukopulos, A., Reginaldi, D., Girardi, P., Tondo, L.Course of manic-depressive recurrences under lithium. Compr Psychiatry 1975;16(6):517–524CrossRef Google Scholar PubMed

Kukopulos, A., Reginaldi, D., Laddomada, P., Floris, G., Serra, G., Tondo, L.Course of the manic-depressive cycle and changes caused by treatment. Pharmakopsychiatr Neuropsychopharmakol 1980;13(4):156–167CrossRef Google Scholar PubMed

Leonhard, K.The classification of endogenous psychoses New YorkIrvington 1957Google Scholar

Malkoff-Schwartz, S., Frank, E., Anderson, B., Hlastala, S., Luther, J., Sherrill, J.et al.Social rhythm disruption and stressful life events in the onset of bipolar and unipolar episodes. Psychol Med 2000;30(5):1005–1016CrossRef Google Scholar PubMed

McElroy, S.L., Keck, P.E., Pope, H.G., Hudson, J.I., Faedda, G.L., Swann, A.C.Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. Am J Psychiatry 1992;149:1633–1644Google Scholar PubMed

Moller, H.J., Grunze, H.Have some guidelines for the treatment of acute bipolar depression gone too far in the restriction of antidepressants?. Eur Arch Psychiatry Clin Neurosci 2000;250(2):57–68Google Scholar PubMed

Moller, H.J., Grunze, H., Broich, K. Do recent efficacy data on the drug treatment of acute bipolar depression support the position that drugs other than antidepressants are the treatment of choice? A conceptual review. Eur Arch Psychiatry Clin Neurosci 2005CrossRef Google Scholar

Moller, H., Steinmeyer, E.Are serotonergic reuptake inhibitors more potent in reducing suicidality? An empirical study on paroxetine. Eur Neuropsychopharmacol 1994;4:55–59CrossRef Google Scholar

Moncrieff, J.Psychiatric drug promotion and the politics of neo-liberalism. Br J Psychiatry 2006;188:301–302CrossRef Google Scholar PubMed

Mundt, C., Reck, C., Backenstrass, M., Kronmuller, K., Fiedler, P.Reconfirming the role of life events for the timing of depressive episodes. A two-year prospective follow-up study. J Affect Disord 2000;59(1):23–30CrossRef Google Scholar PubMed

Naito, M., Kijima, N., Kitamura, T.Temperament and Character Inventory (TCI) as predictors of depression among Japanese college students. J Clin Psychol 2000;56(12):1579–15853.0.CO;2-K>CrossRef Google Scholar PubMed

Nelson, J.C.The STAR*D study: a four-course meal that leaves us wanting more. Am J Psychiatry 2006;163(11):1864–1866CrossRef Google Scholar PubMed

Nemeroff, C.B., Evans, D.L., Gyulai, L., Sachs, G.S., Bowden, C.L., Gergel, I.P.et al.Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. Am J Psychiatry 2001;158(6):906–912CrossRef Google Scholar PubMed

Nierenberg, A.A., Fava, M., Trivedi, M.H., Wisniewski, S.R., Thase, M.E., McGrath, P.J.et al.A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report. Am J Psychiatry 2006;163(9):1519–1530 quiz 1665CrossRef Google Scholar

Norvell, N., Brophy, C., Finch, A.J. Jr.The relationship of anxiety to childhood depression. J Pers Assess 1985;49(2):150–153CrossRef Google Scholar PubMed

Ono, Y., Ando, J., Onoda, N., Yoshimura, K., Momose, T., Hirano, M.et al.Dimensions of temperament as vulnerability factors in depression. Mol Psychiatry 2002;7(9):948–953CrossRef Google Scholar PubMed

Parker, G., Malhi, G.Are atypical antipsychotic drugs also atypical antidepressants?. Aust N Z J Psychiatry 2001;35(5):631–638CrossRef Google Scholar PubMed

Peet, M.Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. Br J Psychiatry 1994;164(4):549–550CrossRef Google Scholar PubMed

Perris, C.A study of bipolar (manic-depressive) and unipolar recurrent depressive psychoses. Acta Psychiatr Scand 1966;42(Suppl 194):15–152CrossRef Google Scholar

Pinel, P.Traité médicophilosophique sur l’alienation mentale ou la manie ParisRichard Caille et Ravier 1801Google Scholar

Popper, K.The logic of scientific discovery New YorkBasic Books 1959Google Scholar

Prien, R.F., Klett, C.J., Caffey, E.M.Lithium carbonate and imipramine in prevention of affective episodes: a comparison in recurrent affective illness. Arch Gen Psychiatry 1973;29:420–425CrossRef Google Scholar PubMed

Prien, R.F., Kupfer, D.J., Mansky, P.A., Small, J.G., Tuason, V.B., Voss, C.B.et al.Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders: a report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination. Arch Gen Psychiatry 1984;41:1096–1104CrossRef Google Scholar

Quine, W.From a logical point of view Cambridge, MAHarvard University Press 2006Google Scholar

Quitkin, F.M., Kane, J., Rifkin, A., Ramos-Lorenzi, J.R., Nayak, D.V.Prophylactic lithium carbonate with and without imipramine for bipolar 1 patients. Arch Gen Psychiatry 1981;38:902–907CrossRef Google Scholar PubMed

Rihmer, Z., Akiskal, H.Do antidepressants t(h)reat(en) depressives? Toward a clinically judicious formulation of the antidepressant-suicidality FDA advisory in light of declining national suicide statistics from many countries. J Affect Disord 2006;94(1-3):3–13CrossRef Google Scholar

Robertson, M.M., Trimble, M.R.Major tranquillisers used as antidepressants: a review. J Affect Disord 1982;4:173–193CrossRef Google Scholar PubMed

Rothschild, A.J., Williamson, D.J., Tohen, M.F., Schatzberg, A., Andersen, S.W., Van Campen, L.E.et al.A double-blind, randomized study of olanzapine and olanzapine/fluoxetine combination for major depression with psychotic features. J Clin Psychopharmacol 2004;24(4):365–373CrossRef Google Scholar PubMed

Rush, A.J., Trivedi, M.H., Wisniewski, S.R., Nierenberg, A.A., Stewart, J.W., Warden, D.et al.Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006;163(11):1905–1917CrossRef Google Scholar PubMed

Sachs, G.S., Nierenberg, A.A., Calabrese, J.R., Marangell, L.B., Wisniewski, S.R., Gyulai, L.et al.Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med 2007;356(17):1711–1722CrossRef Google Scholar PubMed

Sackett, D., Strauss, S., Richardson, W., Rosenberg, W., Haynes, R.Evidence based medicine LondonChurchill Livingstone 2000Google Scholar

Safer, D.J., Zito, J.M.Do antidepressants reduce suicide rates?. Public Health 2007;121(4):274–277CrossRef Google Scholar PubMed

Schatzberg, A.F.Bipolar disorder: recent issues in diagnosis and classification. J Clin Psychiatry 1998;59(Suppl 6):5–10 discussion 11–2Google Scholar PubMed

Schou, M.Normothymotics, “mood-normalizers”: are lithium and the imipramine drugs specific for affective disorders?. Br J Psychiatry 1963;109:803–809CrossRef Google Scholar PubMed

Shorter, E.A history of psychiatry New YorkJohn Wiley and Sons 1997Google Scholar

Silverstone, P.H., von Studnitz, E.Defining anxious depression: going beyond comorbidity. Can J Psychiatry 2003;48(10):675–680CrossRef Google Scholar PubMed

Soldani, F., Ghaemi, S.N., Baldessarini, R.Research methods in psychiatric treatment studies. Critique and proposals. Acta Psychiatr Scand 2005;112(1):1–3Google Scholar PubMed

Spitzer, R.L., Endicott, J., Robins, E.Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry 1978;35:773CrossRef Google Scholar PubMed

Stoll, A.L., Tohen, M., Baldessarini, R.J., Goodwin, D.C., Stein, S., Katz, S.et al.Shifts in diagnostic frequencies of schizophrenia and major affective disorders at six North American psychiatric hospitals, 1972–1988. Am J Psychiatry 1993;150:1668–1673Google Scholar PubMed

Swann, A.C.Depression, mania, and feeling bad: the role of dysphoria in mixed states. Bipolar Disord 2000;2(4):325–327CrossRef Google Scholar PubMed

Thase, M.E., Corya, S.A., Osuntokun, O., Case, M., Henley, D.B., Sanger, T.M.et al.A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder. J Clin Psychiatry 2007;68(2):224–236CrossRef Google Scholar PubMed

Thies-Flechtner, K., Muller-Oerlinghausen, B., Seibert, W., Walther, A., Greil, W.Effect of prophylactic treatment on suicide risk in patients with major affective disorders. Data from a randomized prospective trial. Pharmacopsychiatry 1996;29:103–107CrossRef Google Scholar PubMed

Tohen, M., Vieta, E., Calabrese, J., Ketter, T.A., Sachs, G., Bowden, C.et al.Efficacy of olanzapine and olanzapine–fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry 2003;60(11):1079–1088CrossRef Google Scholar PubMed

Tondo, L., Hennen, J., Baldessarini, R.J.Lower suicide risk with long-term lithium treatment in major affective illness: a meta-analysis. Acta Psychiatr Scand 2001;104(3):163–172CrossRef Google Scholar PubMed

Tondo, L., Jamison, K., Baldessarini, R.Effect of lithium maintenance on suicidal behavior in major mood disordersStoff, D., Mann, J.The neurobiology of suicide: from the bench to the clinic vol. 836 New YorkThe New York Academy of Sciences 1997 339–351Google Scholar

Trivedi, M.H., Rush, A.J., Wisniewski, S.R., Nierenberg, A.A., Warden, D., Ritz, L.et al.Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006;163(1):28–40Google Scholar PubMed

Veleber, D.M., Templer, D.I.Effects of caffeine on anxiety and depression. J Abnorm Psychol 1984;93(1):120–122CrossRef Google Scholar PubMed

Wehr, T.A., Sack, D.A., Rosenthal, N.E., Cowdry, R.W.Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients. Am J Psychiatry 1988;145(2):179–184Google Scholar PubMed

Wenokur, B., Lessem, P.Caffeine withdrawal, metoclopramide, and depression. Am J Gastroenterol 1993;88(9):1464Google Scholar PubMed

Whitman, P.B., Leitenberg, H.Negatively biased recall in children with self-reported symptoms of depression. J Abnorm Child Psychol 1990;18(1):15–27CrossRef Google Scholar PubMed

Winokur, G., Coryell, W., Endicott, J., Akiskal, H.Further distinctions between manic-depressive illness (bipolar disorder) and primary depressive disorder (unipolar depression). Am J Psychiatry 1993;150(8):1176–1181Google Scholar

Kaplan, A. Throughout the times with Frank J. Ayd Jr. M.D. Psychiatric Times, February 11, 2005.Google Scholar

Ghaemi, S.N.The Concepts of Psychiatry BaltimoreJohns Hopkins Univ. Press 2007Google Scholar

Submit a response

Comments

No Comments have been published for this article.